Among broad child behavior questionnaires used to screen for ADHD, the short hyperactivity-inattention subscale of the Strengths and Difficulties Questionnaire (SDQ) has the strongest measurement evidence, according to a 2026 review of 36 studies. None of the 12 scales reviewed met every quality standard.1 Research Highlights 36 studies, 12 scales: a systematic review in BMC …
Nearly 1 in 5 people with COPD in Lithuania had a recorded diagnosis of anxiety or depression, according to a nationwide study of 64,246 patients. Anxiety was far more common than depression, and most patients who received medication were prescribed benzodiazepines.1 Research Highlights 18.1% had a recorded diagnosis: 11,608 of 64,246 adults with COPD in …
In a 2026 Alberta study of 1,070 adults leaving psychiatric hospital care, 40% returned to an emergency department for mental health reasons within a year. The strongest warning signs were social rather than clinical: a recent emergency visit before admission (3.72 times the odds), unstable housing (2.60 times), and unemployment (1.57 times).1 Research Highlights Recent …
A 2026 study of 1,250 Florida youth in juvenile-justice programs who had attempted suicide found that 557 (45%) denied serious suicidal thoughts or a plan. Anger or irritability was more common among them than among youth reporting suicidal thoughts (40% vs. 30%).1 An earlier 427-youth sample found a 40% denial rate.2 Screening that starts with …
A 2026 umbrella review of 16 systematic reviews covering 371 trials found strong medication evidence for tobacco and opioid use disorders, modest benefits for alcohol use disorder, and no approved drugs for stimulant or cannabis use disorders.1 Varenicline more than doubled smoking quit rates vs. placebo, methadone kept people in opioid treatment longer than buprenorphine, …
At entry to US specialty clinics, 34% of 2,951 young people with first-episode psychosis reported suicidal thoughts and 7% had attempted suicide in the previous 6 months. A 2026 Early Psychosis Intervention Network (EPINET) analysis found odds fell 76% for thoughts and 85% for attempts over 2 years of care.1 With no comparison group, the …
A 2026 analysis of 41 randomized studies involving 21,025 adults with schizophrenia found the largest estimated reductions in hostility and aggression for clozapine (standardized mean difference, or SMD, of −0.75), paliperidone (−0.62), and olanzapine (−0.60) vs. placebo.1 Confidence in every comparison was low or very low, the top 3 were not statistically separable, and most …